Provectus Biopharmaceuticals Inc (PVCT)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Provectus Biopharmaceuticals Inc (PVCT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011540
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Provectus Biopharmaceuticals Inc (Provectus), formerly Provectus pharmaceuticals Inc is a biotechnology company that develops pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for recurrent melanoma, PV-10 for metastatic liver cancer and PV-10 for recurrent breast cancer. It offers PH-10 for psoriasis and PH-10 for atopic dermatitis. Provectus conducts research on ongoing clinical trials for indications including breast cancers, melanoma, basal cell carcinoma and squamous cell carcinoma. The company also offers programs and experimental therapeutic in hospitals and institutes in Bethlehem, Houston, Louisville, San Diego, Sydney, Brisbane and Adelaide, among others. Provectus is headquartered in Knoxville, Tennessee, the US.

Provectus Biopharmaceuticals Inc (PVCT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Provectus Biopharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Provectus Biopharmaceuticals Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Provectus Pharma Announces Private Placement Of Shares For Up To US$30 Million 10
Provectus Pharma Completes Private Placement Of Units For US$2.1 Million 11
Provectus Pharma And Its Subsidiaries Complete Private Placement Of Units For US$2.5 Million 12
Provectus Pharma Files Registration Statement For A Public Offering For US$50 Million 13
Provectus Pharma Completes Registered Direct Offering Of US$5.1 Million 14
Provectus Biopharmaceuticals Inc – Key Competitors 16
Provectus Biopharmaceuticals Inc – Key Employees 17
Provectus Biopharmaceuticals Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Nov 10, 2016: Provectus Biopharmaceuticals Reports Third Quarter 2016 Financial Results 19
Aug 09, 2016: Provectus Biopharmaceuticals Reports Second Quarter 2016 Financial Results 20
May 10, 2016: Provectus Biopharmaceuticals Reports First Quarter 2016 Financial Results 21
Mar 30, 2016: Provectus Biopharmaceuticals Reports Fourth Quarter and Year End 2015 Financial Results 22
Corporate Communications 23
Apr 20, 2017: Provectus Biopharmaceuticals Reestablishes Strategic Advisory Board 23
Feb 23, 2017: Provectus Biopharmaceuticals Appoints Bruce Horowitz And Dominic Rodrigues As Special Advisers To The Board Of Directors 24
Dec 28, 2016: Provectus Biopharmaceuticals Terminates Peter Culpepper as Interim CEO and COO 25
Feb 29, 2016: Provectus Biopharmaceuticals Announces Leadership Changes 26
Legal and Regulatory 27
Nov 30, 2016: Provectus Biopharmaceuticals Announces Notification of NYSE MKT Listing Deficiency 27
Mar 16, 2016: Provectus Announces Results of Internal Investigation 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Provectus Biopharmaceuticals Inc, Medical Equipment, Key Facts, 2016 2
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Provectus Biopharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Provectus Biopharmaceuticals Inc, Deals By Market, 2011 to YTD 2017 8
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Provectus Pharma Announces Private Placement Of Shares For Up To US$30 Million 10
Provectus Pharma Completes Private Placement Of Units For US$2.1 Million 11
Provectus Pharma And Its Subsidiaries Complete Private Placement Of Units For US$2.5 Million 12
Provectus Pharma Files Registration Statement For A Public Offering For US$50 Million 13
Provectus Pharma Completes Registered Direct Offering Of US$5.1 Million 14
Provectus Biopharmaceuticals Inc, Key Competitors 16
Provectus Biopharmaceuticals Inc, Key Employees 17
Provectus Biopharmaceuticals Inc, Subsidiaries 18

★海外企業調査レポート[Provectus Biopharmaceuticals Inc (PVCT)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nobel Biocare Services AG:企業の製品パイプライン分析
    Summary Nobel Biocare Services AG (Nobel Biocare), a subsidiary of Danaher Corporation, is a provider of implant-based dental restorations. The company offers various solutions, including dental implant systems; high-precision individualized prosthetics; CAD/CAM systems; diagnostics and treatment pl …
  • Eagle Cement Corporation (EAGLE):企業の財務・戦略的SWOT分析
    Eagle Cement Corporation (EAGLE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Alkane Energy Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Alkane Energy Plc (Alkane Energy), a subsidiary of Basalt Infrastructure Partners LLP, is a diversified company. The company power from coal mine methane and natural gas facilities. It has natural gas, coal bed methane, coal mine methane and shale gas. Alkane Energy design, builds and operat …
  • NRG Energy Inc (NRG)-エネルギー分野:企業M&A・提携分析
    Summary NRG Energy, Inc. (NRG) is an integrated energy company that produces, sells and delivers energy, and energy products and services. The company generates power using diverse sources such as coal, natural gas, nuclear, oil, wind and solar. It trades wholesale energy, capacity, fuel and related …
  • Metsa Group:企業の戦略・SWOT・財務情報
    Metsa Group - Strategy, SWOT and Corporate Finance Report Summary Metsa Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Genoptix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Genoptix Inc (Genoptix) is a hematopathology center which provides oncology diagnostics and informatics services specializing in hematology and solid tumors. The center offers biopharma and healthcare laboratory, discovery, drug development, care and cost development, and patient services. G …
  • REC Silicon ASA (REC):電力:M&Aディール及び事業提携情報
    Summary REC Silicon ASA (REC Silicon), formerly Renewable Energy Corporation ASA, is a producer of advanced silicon materials, and delivers high-purity polysilicon and silicon gas. Its products find application in the solar and electronics industries in the production of solar panels, flat panel dis …
  • Mead Johnson Nutrition Co:企業の戦略的SWOT分析
    Mead Johnson Nutrition Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Kura Oncology Inc (KURA):製薬・医療:M&Aディール及び事業提携情報
    Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics for the treatment of solid tumors and blood cancers. The company’s lead drug candidate Tipifarnib, an inhibitor of farnesyl transferase, an oral investigational drug candi …
  • Alexion Pharmaceuticals, Inc.
    Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Marston’s PLC:企業の戦略・SWOT・財務分析
    Marston's PLC - Strategy, SWOT and Corporate Finance Report Summary Marston's PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Open Text Corporation:企業の戦略・SWOT・財務分析
    Open Text Corporation - Strategy, SWOT and Corporate Finance Report Summary Open Text Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Neuron Biopharma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Neuron Biopharma SA (NBP) is a biotechnology company that discovers and develops biosolutions. The company offers pharmaceutical compounds to prevent and treat various neurodegenerative diseases. It discovers and assesses nutraceuticals, and development of diagnostic methods for the treatmen …
  • Thai Oil Public Company Limited:企業の戦略・SWOT・財務分析
    Thai Oil Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thai Oil Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Transnet SOC Ltd:企業の戦略的SWOT分析
    Transnet SOC Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Arup Group Ltd:企業の戦略的SWOT分析
    Arup Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Rotala Plc:企業の戦略・SWOT・財務情報
    Rotala Plc - Strategy, SWOT and Corporate Finance Report Summary Rotala Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Advanced Data Systems Corp-医療機器分野:企業M&A・提携分析
    Summary Advanced Data Systems Corp (ADS) is a healthcare technology company that develops medical billing and office automation software tools. The company offers electronic health records, practice management solution, radiology information systems solutions, revenue cycle management services and b …
  • Candover Investments plc:企業の戦略的SWOT分析
    Candover Investments plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Assertio Therapeutics Inc (ASRT):企業の財務・戦略的SWOT分析
    Assertio Therapeutics Inc (ASRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆